JohnKingreyMD

Pulmonology • Oklahoma City, OK

Critical Care Medicine, Interstitial Lung Diseases, Pleural Disease, Pulmonary Vascular Medicine

Director, Pulmonary Hypertension Center Oklahoma Heart Hospital

Join to view full profile

Dr. Kingrey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kingrey's full profile

Already have an account?

Office
Oklahoma Heart Hospital
4050 W Memorial Road
Oklahoma City, OK 73120
Phone+1 405-608-4644

Fax+1 405-242-5911
Is this information wrong?

Education & Training

Ohio State University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2014
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2007 - 2010
Saint Louis University School of MedicineClass of 2007

Certifications & Licensure

OK State Medical License 2014 - 2025
OH State Medical License 2007 - 2014
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Start of enrollment: 2017 Apr 18
Terminated
Phase 3
Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH Start of enrollment: 2018 Jul 15
Terminated
Phase 2

Publications & Presentations

PubMed

Parenteral treprostinil induction for rapid attainment of therapeutic doses of oral treprostinil.
Chad E Miller, Veronica Franco, Jimmy S Smith, Vijay Balasubramanian, John Kingrey, Ronald Zolty, Lana Melendres-Groves, Jessica Huston, Jean M Elwing, Ashwin Ravichan...> ;Respiratory Medicine. 2023 Nov 1
3 citations
Provider recognition and response to echocardiographic findings indicating pulmonary hypertension in the Veterans affairs medical center population.
John F. Kingrey, Ralph J. Panos, Jun Ying, Karthikeyan Meganathan, Robin Vandivier, Jean M. Elwing> ;Pulmonary Circulation. 2013 Apr 1

Press Mentions

United Therapeutics Announces Top Line Data from the EXPEDITE Study of Remodulin Induction Prior to Orenitram TherapyOctober 31st, 2022
United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 MeetingOctober 22nd, 2020

Hospital Affiliations

Mercy Hospital Fort SmithFort Smith, Arkansas
INTEGRIS Baptist Medical CenterOklahoma City, Oklahoma
Jack C. Montgomery Department of Veterans Affairs Medical CenterMuskogee, Oklahoma